Blood Pressure Management During Surgery for High Blood Pressure
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if tightly managing blood pressure during major surgeries can reduce serious complications such as heart problems, stroke, infections, or death within 30 days post-operation. Participants will receive either tight blood pressure management with specific medications (vasopressors) or usual care to assess which approach is more effective. Ideal candidates are over 45 years old, scheduled for major surgeries, and have conditions like diabetes requiring medication or a history of heart disease.
As an unphased trial, this study provides participants the chance to contribute to important research that could enhance surgical outcomes for many patients.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it does require that you are already taking at least one medication for high blood pressure. It's best to discuss this with the trial team or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that carefully controlling blood pressure during surgery is safe. Studies have found that this approach stabilizes blood pressure and reduces the risk of it dropping too low during the operation, making significant drops less likely.
Regarding medications used to maintain blood pressure, norepinephrine and phenylephrine are generally well-tolerated, according to research. These drugs help keep blood pressure steady during surgery. Studies have found that they do not cause serious kidney problems and are safe for use during operations.
Overall, both careful blood pressure management and the use of these medications have demonstrated promising safety results in previous studies.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores different strategies for managing blood pressure during surgery in patients with hypertension. The "tight blood pressure management" approach is unique as it specifically avoids the use of certain medications like ACE inhibitors and ARBs on the morning of surgery, and instead relies on norepinephrine or phenylephrine to maintain a higher intraoperative blood pressure. This contrasts with the "routine blood pressure management" that allows the use of standard medications as needed. By testing these approaches, researchers hope to find out if tightly controlling blood pressure with specific infusions offers better outcomes for surgical patients compared to usual care.
What evidence suggests that this trial's treatments could be effective for managing blood pressure during surgery?
Research has shown that carefully controlling blood pressure during surgery helps maintain a healthy level, reducing the risk of low blood pressure linked to heart or kidney issues. This trial will compare two approaches: tight blood pressure management and routine blood pressure management. In the tight blood pressure management arm, medications such as norepinephrine and phenylephrine maintain stable blood pressure during surgery. Studies have found that this careful approach may lower the chances of serious complications after surgery. In short, closely managing blood pressure during surgery could lead to fewer complications and a smoother recovery.16789
Who Is on the Research Team?
Daniel I Sessler, MD
Principal Investigator
The University of Texas Health Science Center, Houston
Are You a Good Fit for This Trial?
The GUARDIAN Trial is for adults over 45 with high blood pressure who are taking medication for it and scheduled for major noncardiac surgery lasting at least 2 hours. They must be hospitalized overnight, have a certain level of systemic disease, direct blood pressure monitoring during surgery, and one additional risk factor like heart disease or diabetes. Exclusions include those needing organ transplants or specific surgeries, contraindications to the study drugs, or cognitive impairments.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either tight or routine intraoperative blood pressure management during surgery
Postoperative Monitoring
Participants are monitored for major perfusion-related complications and other outcomes
Follow-up
Participants are monitored for cognition and major adverse cardiac events
What Are the Treatments Tested in This Trial?
Interventions
- Routine pressure management
- Tight pressure management
- Vasopressor
Trial Overview
This trial tests two ways to manage blood pressure during major surgery: 'tight' management aims to keep intraoperative mean arterial pressure (MAP) ≥85 mmHg using norepinephrine or phenylephrine infusions; 'routine' management follows standard care without this strict MAP target.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
In patients assigned to tight blood pressure control, angiotensin converting enzyme inhibitors and angiotensin receptor blockers will not be given the morning of surgery. Other chronic antihypertensives will only be given as necessary to treat hypertension. Norepinephrine or phenylephrine infusion will be infused at a rate sufficient to maintain intraoperative MAP ≥ 85 mmHg.
ACEIs, ARBs, and/or calcium channel blockers can be given the morning of surgery if deemed appropriate by the attending anesthesiologist. Intraoperative blood pressure will be managed per clinical routine.
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Cleveland Clinic
Lead Sponsor
The University of Texas Health Science Center, Houston
Lead Sponsor
Published Research Related to This Trial
Citations
Tight perioperative blood pressure management to reduce ...
Tight BP management markedly increased intraoperative MAP and reduced the amount of hypotension. In contrast, delaying chronic antihypertensive medications had ...
PeriOperative Quality Initiative (POQI) international ...
This article presents updated consensus statements and recommendations on perioperative arterial pressure management developed during the 11th POQI ...
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...
An increasing number of individual studies and meta-analyses of observational data have reported a gradient of higher CVD risk from normal BP, ...
Study Details | NCT05416944 | Perioperative Personalized ...
Rates of major complications and mortality in the first weeks after surgery remain very high: postoperative mortality is still around 2% in central Europe ...
Intensive vs Conventional Intraoperative Blood Pressure ...
Objectives: The purpose of this study was to determine whether intensive intraoperative blood pressure management reduces the incidence of a ...
Intensive vs Conventional Intraoperative Blood Pressure ...
Patients assigned to intensive intraoperative blood pressure management experienced a lower burden of hypotension exposure, as assessed by ...
7.
journals.lww.com
journals.lww.com/cmj/fulltext/2025/01200/intraoperative_targeted_blood_pressure_management.18.aspxIntraoperative targeted blood pressure management and...
With regard to safety outcomes, the patients assigned to targeted blood pressure management developed less severe intraoperative hypotension ...
PeriOperative Quality Initiative (POQI) international ...
This article presents updated consensus statements and recommendations on perioperative arterial pressure management developed during the 11th POQI ...
Tight perioperative blood pressure management to reduce ...
Conclusions Tight BP management markedly increased intraoperative MAP and reduced the amount of hypotension. In contrast, delaying chronic.
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.